{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-021552","form_type":"8-K","ticker":"PTIX","cik":"0001022899","company_name":"Protagenic Therapeutics, Inc.new","filed_at":"2025-07-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.144699+00:00","generated_at":"2026-05-17T22:44:14.309950+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Protagenic Therapeutics granted Japan patent for modified stilbenoid epilepsy drug candidates","bullets":["Japanese Patent Office granted Patent JP 7714571B on July 18, 2025, covering modified stilbenoid compounds.","Patent runs until March 31, 2041, providing exclusivity for treating epilepsy and seizures.","Builds on previously granted UK patent GB2609814 for same program.","Japanese pharma market worth >$85B; global epilepsy drug market expected to reach $18.7B by 2034.","Company expects to expand patent protection to other territories."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-021552","json":"https://secwatch.observer/filing/0001641172-25-021552.json","markdown":"https://secwatch.observer/filing/0001641172-25-021552.md","text":"https://secwatch.observer/filing/0001641172-25-021552.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022899/000164117225021552/0001641172-25-021552-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022899/000164117225021552/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T22:44:14.309950+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}